학술논문
Talazoparib monotherapy in metastatic castration-resistant prostate cancer with DNA repair alterations (TALAPRO-1): an open-label, phase 2 trial
Document Type
Article
Author
de Bono, Johann S ; Mehra, Niven; Scagliotti, Giorgio V; Castro, Elena; Dorff, Tanya; Stirling, Adam; Stenzl, Arnulf; Fleming, Mark T; Higano, Celestia S; Saad, Fred; Buttigliero, Consuelo; van Oort, Inge M; Laird, A Douglas; Mata, Marielena; Chen, Hsiang-Chun; Healy, Cynthia G; Czibere, Akos; Fizazi, Karim
Source
In The Lancet Oncology September 2021 22(9):1250-1264
Subject
Language
ISSN
1470-2045